Astellas Pharma GmbH divests German and Austrian assets

Paolo Bossi Europe, Europe Legal Chronicle

Jones Day has advised Astellas Pharma GmbH in its divestiture of certain German and Austrian Rx and OTC product assets. Jones Day advised Astellas Pharma GmbH…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Paolo Bossi

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here